{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:06:38Z","timestamp":1790028398605,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03554-9","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:30:51Z","timestamp":1790026251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detecting Crystallization in Spray-dried Amorphous Solid Dispersion Tablets Administered in Apple Sauce: Feasibility, Challenges and Considerations"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6292-8996","authenticated-orcid":false,"given":"Paroma","family":"Chakravarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4327-9410","authenticated-orcid":false,"given":"Minhthi","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9556-2877","authenticated-orcid":false,"given":"Kellie K.","family":"Sluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0379-0821","authenticated-orcid":false,"given":"Bifan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9571-9225","authenticated-orcid":false,"given":"Simon","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3664-5885","authenticated-orcid":false,"given":"Hao Helen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"3554_CR1","unstructured":"Food U, Administration D. Use of liquids and\/or soft foods as vehicles for drug administration: general considerations for selection and in vitro methods for product quality assessments. US Department of Health and Human Services; 2018. 2023."},{"issue":"3","key":"3554_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ajps.2019.05.003","volume":"15","author":"HS Lee","year":"2020","unstructured":"Lee HS, Lee J-J, Kim M-G, Kim K-T, Cho C-W, Kim D-D, et al. Sprinkle formulations\u2014a review of commercially available products. Asian J Pharm Sci. 2020;15(3):292\u2013310. https:\/\/doi.org\/10.1016\/j.ajps.2019.05.003.","journal-title":"Asian J Pharm Sci"},{"issue":"8","key":"3554_CR3","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1177\/10781552211037976","volume":"27","author":"C Wagner","year":"2021","unstructured":"Wagner C, Adams V, Overley C. Alternate dosage formulations of oral targeted anticancer agents. J Oncol Pharm Pract. 2021;27(8):1963\u201381. https:\/\/doi.org\/10.1177\/10781552211037976.","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"3554_CR4","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/ijms20071718","volume":"20","author":"JB Morris","year":"2019","unstructured":"Morris JB, Tisi DA, Tan DCT, Worthington JH. Development and palatability assessment of Norvir\u00ae 100 mg powder for pediatric population. Int J Mol Sci. 2019;20(7):1718. https:\/\/doi.org\/10.3390\/ijms20071718.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3554_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2165\/00044011-200121010-00009","volume":"21","author":"T Andersson","year":"2001","unstructured":"Andersson T, Magner D, Patel J, Rogers P, Levine JG. Esomeprazole 40mg capsules are bioequivalent when administered intact or as the contents mixed with applesauce. Clin Drug Investig. 2001;21(1):67\u201371. https:\/\/doi.org\/10.2165\/00044011-200121010-00009.","journal-title":"Clin Drug Investig"},{"key":"3554_CR6","doi-asserted-by":"publisher","unstructured":"Chun SC, Nwakama PE, Patel DT, Ren K, Braddy AC. Reconciling sprinkle administration information in approved NDA labeling with sprinkle bioequivalence study recommendations in FDA product-specific guidances for generic drug development. Am J Pharmacother Pharm Sci. 2022;12. https:\/\/doi.org\/10.25259\/AJPPS_18_2022.","DOI":"10.25259\/AJPPS_18_2022"},{"issue":"6","key":"3554_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/0091270005276203","volume":"45","author":"M Chung","year":"2005","unstructured":"Chung M, Garza D, Gaffney M, Glue P. Bioavailability of amlodipine besylate following oral administration as a tablet dispersed in applesauce. J Clin Pharmacol. 2005;45(6):695\u2013700. https:\/\/doi.org\/10.1177\/0091270005276203.","journal-title":"J Clin Pharmacol"},{"key":"3554_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2025.114868","author":"C Eckert","year":"2025","unstructured":"Eckert C, Stillhart C, Wagner L, Scheubel E, Prevot I, Lindenberg M, et al. Towards the development of a standard toolbox for compatibility testing of pediatric drug products with common dosing vehicles\u2212 fruit juice, apple sauce, yogurt, and pudding. Eur J Pharm Biopharm. 2025. https:\/\/doi.org\/10.1016\/j.ejpb.2025.114868.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"3554_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11095-022-03208-y","volume":"39","author":"L Freerks","year":"2022","unstructured":"Freerks L, Sucher W, Tarnow M-J, Eckert C, Klein S. Vehicles for drug administration to children: results and learnings from an in-depth screening of FDA-recommended liquids and soft foods for product quality assessment. Pharm Res. 2022;39(3):497\u2013509. https:\/\/doi.org\/10.1007\/s11095-022-03208-y.","journal-title":"Pharm Res"},{"issue":"8","key":"3554_CR10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.5863\/1551-6776-25.8.723","volume":"25","author":"C Gillium","year":"2020","unstructured":"Gillium C, Friciu M, Abatzoglou N, Leclair G. Stability of extemporaneously prepared acetazolamide oral suspensions at two temperatures. J Pediatr Pharmacol Ther. 2020;25(8):723\u20139. https:\/\/doi.org\/10.5863\/1551-6776-25.8.723.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"3554_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1691\/ph.2016.5145","volume":"71","author":"E Kersten","year":"2016","unstructured":"Kersten E, Barry A, Klein S. Physicochemical characterisation of fluids and soft foods frequently mixed with oral drug formulations prior to administration to children. Pharmazie. 2016;71(3):122\u20137. https:\/\/doi.org\/10.1691\/ph.2016.5145.","journal-title":"Pharmazie"},{"issue":"7","key":"3554_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.5863\/1551-6776-27.7.618","volume":"27","author":"O Rahi\u0107","year":"2022","unstructured":"Rahi\u0107 O, Had\u017eiabdi\u0107 J, Tucak A, Sirbubalo M, Hindija L, Elezovi\u0107 A, et al. A critical assessment of extemporaneous formulations for proton pump inhibitors: the importance of proper vehicle selection. J Pediatr Pharmacol Ther. 2022;27(7):618\u201324. https:\/\/doi.org\/10.5863\/1551-6776-27.7.618.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"3554_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122737","volume":"635","author":"K-W Wu","year":"2023","unstructured":"Wu K-W, Zheng K, Tian L, Xia L, Hwang S-Y, Nwakama PE, et al. The effect of food vehicles on in vitro performance of pantoprazole sodium delayed release sprinkle formulation. Int J Pharm. 2023;635:122737. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122737.","journal-title":"Int J Pharm"},{"issue":"1","key":"3554_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s41120-023-00082-9","volume":"9","author":"A Yu","year":"2023","unstructured":"Yu A, Ackaert O. Bioequivalence clinical trial simulation: a case study of apalutamide administered in applesauce versus whole tablets. AAPS Open. 2023;9(1):15. https:\/\/doi.org\/10.1186\/s41120-023-00082-9.","journal-title":"AAPS Open"},{"issue":"11","key":"3554_CR15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/cpdd.1001","volume":"10","author":"A Yu","year":"2021","unstructured":"Yu A, Erba M, Hazra A. Pharmacokinetics and use\u2010testing of apalutamide prepared in aqueous food vehicles for alternative administration. Clin Pharm Drug Dev. 2021;10(11):1375\u201384. https:\/\/doi.org\/10.1002\/cpdd.1001.","journal-title":"Clin Pharm Drug Dev"},{"issue":"9","key":"3554_CR16","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","volume":"105","author":"S Baghel","year":"2016","unstructured":"Baghel S, Cathcart H, O\u2019Reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci. 2016;105(9):2527\u201344. https:\/\/doi.org\/10.1016\/j.xphs.2015.10.008.","journal-title":"J Pharm Sci"},{"issue":"4","key":"3554_CR17","first-page":"335","volume":"10","author":"R Bettini","year":"2000","unstructured":"Bettini R, Giordano F, Donini C, Massimo G, Catellani P, Colombo P. Swelling force development as a result of hydrate formation in diclofenac sodium or nitrofurantoin tablets. STP Pharma Sciences. 2000;10(4):335\u201340.","journal-title":"STP Pharma Sciences"},{"key":"3554_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116276","volume":"140","author":"P Chakravarty","year":"2021","unstructured":"Chakravarty P, Nagapudi K. The importance of water-solid interactions in small molecule drug development: an industry perspective. Trends Anal Chem. 2021;140:116276. https:\/\/doi.org\/10.1016\/j.trac.2021.116276.","journal-title":"Trends Anal Chem"},{"issue":"4","key":"3554_CR19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/jps.23020","volume":"101","author":"P Chakravarty","year":"2012","unstructured":"Chakravarty P, Suryanarayanan R, Govindarajan R. Phase transformation in thiamine hydrochloride tablets: influence on tablet microstructure, physical properties, and performance. J Pharm Sci. 2012;101(4):1410\u201322. https:\/\/doi.org\/10.1002\/jps.23020.","journal-title":"J Pharm Sci"},{"key":"3554_CR20","doi-asserted-by":"publisher","unstructured":"Govindarajan R, Suryanarayanan R. Processing\u2010induced phase transformations and their implications on pharmaceutical product quality. In: Hilfiker, R, editor. Polymorphism: in the Pharmaceutical Industry. Wiley\u2010VCH Verlag GmbH & Co. KGaA; 2006. p. 333\u201364. https:\/\/doi.org\/10.1002\/9783527697847.ch1.","DOI":"10.1002\/9783527697847.ch1"},{"issue":"9","key":"3554_CR21","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1023\/A:1020621906855","volume":"19","author":"A J\u00f8rgensen","year":"2002","unstructured":"J\u00f8rgensen A, Rantanen J, Karjalainen M, Khriachtchev L, R\u00e4s\u00e4nen E, Yliruusi J. Hydrate formation during wet granulation studied by spectroscopic methods and multivariate analysis. Pharm Res. 2002;19(9):1285\u201391. https:\/\/doi.org\/10.1023\/A:1020621906855.","journal-title":"Pharm Res"},{"key":"3554_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejpb.2018.07.005","volume":"130","author":"MM Knopp","year":"2018","unstructured":"Knopp MM, Wendelboe J, Holm R, Rades T. Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion. Eur J Pharm Biopharm. 2018;130:290\u20135. https:\/\/doi.org\/10.1016\/j.ejpb.2018.07.005.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"3554_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1021\/acs.molpharmaceut.6b01052","volume":"14","author":"S Koranne","year":"2017","unstructured":"Koranne S, Govindarajan R, Suryanarayanan R. Investigation of spatial heterogeneity of salt disproportionation in tablets by synchrotron X-ray diffractometry. Mol Pharm. 2017;14(4):1133\u201344. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b01052.","journal-title":"Mol Pharm"},{"issue":"8","key":"3554_CR24","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/jps.20640","volume":"95","author":"S Mirza","year":"2006","unstructured":"Mirza S, Hein\u00e4m\u00e4ki J, Miroshnyk I, Rantanen J, Christiansen L, Karjalainen M, et al. Understanding processing-induced phase transformations in erythromycin\u2013PEG 6000 solid dispersions. J Pharm Sci. 2006;95(8):1723\u201332. https:\/\/doi.org\/10.1002\/jps.20640.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3554_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.xphs.2022.03.020","volume":"112","author":"DE Moseson","year":"2023","unstructured":"Moseson DE, Hiew TN, Su Y, Taylor LS. Formulation and processing strategies which underpin susceptibility to matrix crystallization in amorphous solid dispersions. J Pharm Sci. 2023;112(1):108\u201322. https:\/\/doi.org\/10.1016\/j.xphs.2022.03.020.","journal-title":"J Pharm Sci"},{"key":"3554_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/978-1-4939-1598-9_17","volume-title":"Amorphous solid dispersions: theory and practice","author":"Z Rahman","year":"2014","unstructured":"Rahman Z, Siddiqui A, Gupta A, Khan M. Regulatory considerations in development of amorphous solid dispersions. In: Shah N, Sandhu H, Choi DS, Chokshi H, Malick AW, editors. Amorphous solid dispersions: theory and practice. Springer; 2014. p. 545\u201363. https:\/\/doi.org\/10.1007\/978-1-4939-1598-9_17."},{"issue":"12","key":"3554_CR27","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1023\/A:1018951309506","volume":"16","author":"BR Rohrs","year":"1999","unstructured":"Rohrs BR, Thamann TJ, Gao P, Stelzer DJ, Bergren MS, Chao RS. Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant. Pharm Res. 1999;16(12):1850\u20136. https:\/\/doi.org\/10.1023\/A:1018951309506.","journal-title":"Pharm Res"},{"issue":"12","key":"3554_CR28","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1007\/s11095-009-9974-3","volume":"26","author":"AC Rumondor","year":"2009","unstructured":"Rumondor AC, Stanford LA, Taylor LS. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm Res. 2009;26(12):2599\u2013606. https:\/\/doi.org\/10.1007\/s11095-009-9974-3.","journal-title":"Pharm Res"},{"key":"3554_CR29","unstructured":"Salameh AK. Moisture induced phase transformation in multi-component systems. Purdue University; 2005."},{"issue":"10","key":"3554_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.4155\/tde.14.68","volume":"5","author":"J Sood","year":"2014","unstructured":"Sood J, Sapra B, Bhandari S, Jindal M, Tiwary AK. Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions. Ther Deliv. 2014;5(10):1123\u201342. https:\/\/doi.org\/10.4155\/tde.14.68.","journal-title":"Ther Deliv"},{"issue":"5","key":"3554_CR31","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/jps.22405","volume":"100","author":"GA Stephenson","year":"2011","unstructured":"Stephenson GA, Aburub A, Woods TA. Physical stability of salts of weak bases in the solid-state. J Pharm Sci. 2011;100(5):1607\u201317. https:\/\/doi.org\/10.1002\/jps.22405.","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"3554_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijpharm.2017.02.001","volume":"520","author":"NK Thakral","year":"2017","unstructured":"Thakral NK, Kelly RC. Salt disproportionation: a material science perspective. Int J Pharm Sci. 2017;520(1\u20132):228\u201340. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.001.","journal-title":"Int J Pharm Sci"},{"issue":"8","key":"3554_CR33","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1021\/mp400180n","volume":"10","author":"NK Thakral","year":"2013","unstructured":"Thakral NK, Ragoonanan V, Suryanarayanan R. Quantification, mechanism, and mitigation of active ingredient phase transformation in tablets. Mol Pharm. 2013;10(8):3128\u201336. https:\/\/doi.org\/10.1021\/mp400180n.","journal-title":"Mol Pharm"},{"issue":"10","key":"3554_CR34","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/jps.2600821004","volume":"82","author":"JT Wang","year":"1993","unstructured":"Wang JT, Shiu GK, Ong-Chen T, Viswanathan C, Skelly JP. Effects of humidity and temperature on in vitro dissolution of carbamazepine tablets. J Pharm Sci. 1993;82(10):1002\u20135. https:\/\/doi.org\/10.1002\/jps.2600821004.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3554_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jps.23358","volume":"102","author":"LA Wegiel","year":"2013","unstructured":"Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage\u2014impact of different polymers. J Pharm Sci. 2013;102(1):171\u201384. https:\/\/doi.org\/10.1002\/jps.23358.","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"3554_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0378-5173(02)00380-0","volume":"247","author":"T Yoshinari","year":"2002","unstructured":"Yoshinari T, Forbes RT, York P, Kawashima Y. Moisture induced polymorphic transition of mannitol and its morphological transformation. Int J Pharm Sci. 2002;247(1\u20132):69\u201377. https:\/\/doi.org\/10.1016\/S0378-5173(02)00380-0.","journal-title":"Int J Pharm Sci"},{"issue":"3","key":"3554_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.addr.2003.10.009","volume":"56","author":"GG Zhang","year":"2004","unstructured":"Zhang GG, Law D, Schmitt EA, Qiu Y. Phase transformation considerations during process development and manufacture of solid oral dosage forms. Adv Drug Deliv Rev. 2004;56(3):371\u201390. https:\/\/doi.org\/10.1016\/j.addr.2003.10.009.","journal-title":"Adv Drug Deliv Rev"},{"issue":"20","key":"3554_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ma16206616","volume":"16","author":"L Corrie","year":"2023","unstructured":"Corrie L, Ajjarapu S, Banda S, Parvathaneni M, Bolla PK, Kommineni N. HPMCAS-based amorphous solid dispersions in clinic: a review on manufacturing techniques (hot melt extrusion and spray drying), marketed products and patents. Materials (Basel). 2023;16(20):6616. https:\/\/doi.org\/10.3390\/ma16206616.","journal-title":"Materials (Basel)"},{"issue":"2","key":"3554_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1208\/s12248-016-0017-9","volume":"19","author":"J Li","year":"2017","unstructured":"Li J, Patel D, Wang G. Use of spray-dried dispersions in early pharmaceutical development: theoretical and practical challenges. AAPS J. 2017;19(2):321\u201333. https:\/\/doi.org\/10.1208\/s12248-016-0017-9.","journal-title":"AAPS J"},{"key":"3554_CR40","unstructured":"Manu JS, Ganesh LB, Manoj BM, Randhir CB, Shashikant BD, Chirag SB. Spray drying in pharmaceutical industry: a review. Res J Pharm Dosage Forms Technol. 2012;4(2):II."},{"key":"3554_CR41","doi-asserted-by":"publisher","unstructured":"Moseson DE, Tran TB, Karunakaran B, Ambardekar R, Hiew TN. Trends in amorphous solid dispersion drug products approved by the US Food and Drug Administration between 2012 and 2023. Int J Pharm X. 2024;7:100259. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100259.","DOI":"10.1016\/j.ijpx.2024.100259"},{"issue":"4","key":"3554_CR42","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/jps.23031","volume":"101","author":"A Newman","year":"2012","unstructured":"Newman A, Knipp G, Zografi G. Assessing the performance of amorphous solid dispersions. J Pharm Sci. 2012;101(4):1355\u201377. https:\/\/doi.org\/10.1002\/jps.23031.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3554_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijpharm.2012.07.015","volume":"453","author":"A Paudel","year":"2013","unstructured":"Paudel A, Worku ZA, Meeus J, Guns S, Van den Mooter G. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm. 2013;453(1):253\u201384. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.07.015.","journal-title":"Int J Pharm"},{"issue":"1","key":"3554_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13346-019-00648-9","volume":"10","author":"AH Salama","year":"2020","unstructured":"Salama AH. Spray drying as an advantageous strategy for enhancing pharmaceuticals bioavailability. Drug Deliv Transl Res. 2020;10(1):1\u201312. https:\/\/doi.org\/10.1007\/s13346-019-00648-9.","journal-title":"Drug Deliv Transl Res"},{"key":"3554_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2015.12.010","volume":"100","author":"A Singh","year":"2016","unstructured":"Singh A, Van den Mooter G. Spray drying formulation of amorphous solid dispersions. Adv Drug Deliv Rev. 2016;100:27\u201350. https:\/\/doi.org\/10.1016\/j.addr.2015.12.010.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"3554_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2023.100834","volume":"18","author":"J Zhang","year":"2023","unstructured":"Zhang J, Guo M, Luo M, Cai T. Advances in the development of amorphous solid dispersions: the role of polymeric carriers. Asian J Pharm Sci. 2023;18(4):100834. https:\/\/doi.org\/10.1016\/j.ajps.2023.100834.","journal-title":"Asian J Pharm Sci"},{"key":"3554_CR47","unstructured":"Janssen Biotech I. [FDA label]. 2020 [cited 2020 July 2020]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/210951s002lbl.pdf."},{"key":"3554_CR48","unstructured":"McGlynn W. Importance of food pH in commercial canning operations [superseded]. 2003."},{"issue":"8","key":"3554_CR49","first-page":"1612","volume":"40","author":"DA Skoog","year":"1994","unstructured":"Skoog DA, Leary JJ. Principles of instrumental analysis. Clin Chem-Ref Ed. 1994;40(8):1612.","journal-title":"Clin Chem-Ref Ed"},{"issue":"1","key":"3554_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11095-005-7626-9","volume":"15","author":"R Surana","year":"2000","unstructured":"Surana R, Suryanarayanan R. Quantitation of crystallinity in substantially amorphous pharmaceuticals and study of crystallization kinetics by X-ray powder diffractometry. Powder Diffr. 2000;15(1):2\u20136. https:\/\/doi.org\/10.1007\/s11095-005-7626-9.","journal-title":"Powder Diffr"},{"key":"3554_CR51","unstructured":"Ibrahim FML, Mullarney MP, Shanker RM, Spong BR, Wang J. Solid dosage forms of palbociclib. US Patent 11,065,250 B2."},{"key":"3554_CR52","unstructured":"Kaufman MD, Bone S, Bloom C, Jordan F. Amorphous kinase inhibitor formulations and methods of use thereof. US Patent 11,576,903 B2."},{"key":"3554_CR53","unstructured":"ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. ICH Harmonised Tripartite Guideline; European Medicines Agency. 1999."},{"issue":"1","key":"3554_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11095-023-03629-3","volume":"41","author":"KA Frey","year":"2024","unstructured":"Frey KA, Baker H, Purcell DK, Lewis AL, Engers DA. Use of resonant acoustic mixing technology for ultra-low-dose blending in a single-step mixing process. Pharm Res. 2024;41(1):165\u201383. https:\/\/doi.org\/10.1007\/s11095-023-03629-3.","journal-title":"Pharm Res"},{"issue":"5","key":"3554_CR55","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02262-4","volume":"23","author":"S Gupta","year":"2022","unstructured":"Gupta S, Pu YE, Li M, Li Z, Osorio JG. Assessment of resonant acoustic mixing for low-dose pharmaceutical powder blends. AAPS PharmSciTech. 2022;23(5):126. https:\/\/doi.org\/10.1208\/s12249-022-02262-4.","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"3554_CR56","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijpharm.2014.05.003","volume":"473","author":"DH Leung","year":"2014","unstructured":"Leung DH, Lamberto DJ, Liu L, Kwong E, Nelson T, Rhodes T, et al. A new and improved method for the preparation of drug nanosuspension formulations using acoustic mixing technology. Int J Pharm. 2014;473(1\u20132):10\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.05.003.","journal-title":"Int J Pharm"},{"key":"3554_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.powtec.2015.02.033","volume":"278","author":"JG Osorio","year":"2015","unstructured":"Osorio JG, Muzzio FJ. Evaluation of resonant acoustic mixing performance. Powder Technol. 2015;278:46\u201356. https:\/\/doi.org\/10.1016\/j.powtec.2015.02.033.","journal-title":"Powder Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03554-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03554-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03554-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:30:55Z","timestamp":1790026255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03554-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3554"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03554-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"301"}}